Primary Record
Dovitinib lactate
- In stock
- 1,269 g
- Purity
- 98.9 %
- CAS
- 915769-50-5
Compound Identifiers & Properties
- CAS
- 915769-50-5
- PubChem CID
- 135611162
- SMILES
- CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N.O
- Canonical SMILES
- CC(O)C(=O)O.CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1.O
Names & Synonyms
- Dovitinib lactate
- Dovitinib
- Dovitinib Lactate Hydrate
- 915769-50-5
- Dovitinib lactate [USAN]
- Tki258 (hydrate)
- Chir 258
- Chir-258 (hydrate)
- TKI258
- UNII-69VKY8P7EA
- 69VKY8P7EA
- Dovitinib lactate monohydrate
- CHIR-258
- Dovitinib (lactate hydrate)
- Dovitinib (TKI258) Lactate
- TKI258 lactate hydrate
- RefChem:135717
- TKI 258
- Dovitinib lactate (USAN)
- Dovitinib lactate(TKI258)
- 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate hydrate
- SCHEMBL253994
- SCHEMBL945391
- orb1300733
- Dovitinib (TKI258) Lactate?
- CHEMBL4297063
- SCHEMBL29351344
- SCHEMBL29435017
- C24H29FN6O5
- CTK8B8638
- Dovitinib lactate hydrate (JAN)
- TKI-258
- (+/-)-DOVITINIB LACTATE
- DTXSID001366253
- GLXC-05092
- DOVITINIB LACTATE [WHO-DD]
- EX-A1642
- HY-B0062
- AN-564
- ANW-60941
- MFCD10565680
- MFCD18251526
- MFCD22422458
- C21H21FN6O.C3H6O3.H2O
- CHIR-258 (TKI-258,Dovitinib)
- DOVITINIB LACTATE, (+/-)-
- AKOS015895483
- AC-8523
- ACN-040204
- BCP9000624
- DOVITINIB LACTATE HYDRATE [JAN]
- FD65011
- VA12007
- KS-0000002N
- 4CA-0371
- PD121579
- TS-09326
- BCP0726000101
- CS-0006523
- Y0274
- D08907
- G92385
- 769D505
- A843990
- I06-1063
- Q27264378
- Propanoic acid, 2-hydroxy-, compd. with 4-amino-5-fluoro-3-(6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl)-2(1H)-quinolinone, hydrate (1:1:1)
- (3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one;2-hydroxypropanoic acid;hydrate
- 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one mono 2-hydroxypropanoate hydrate
- 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one;2-hydroxypropanoic acid;hydrate
- (3E)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one; 2-hydroxypropanoic acid; hydrate
- (3E)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one;2-hydroxypropanoic acid;hydrate
- (Z)-4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)quinolin-2(3H)-one 2-hydroxypropanoate hydrate
- 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxy
- 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzodimidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate hydrate
- 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate hydrate (1 :1 :1)
- 4-Amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one mono 2-hydroxypropanoate hydrate
- 405169-16-6